Key Insights

Highlights

Treatment Research

2 treatments under study, led by Internal Limiting Membrane Transplantation Ilmt

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

50.0%

1 terminated out of 2 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Terminated1
Unknown1

Clinical Trials (2)

Research Network

Common Treatments

  • Internal Limiting Membrane Transplantation Ilmt1
  • Corneal Flap Transplantation1

Active Sponsors

  • First People's Hospital of Hangzhou1
  • Groupe Hospitalier de la Region de Mulhouse et Sud Alsace1

Top Investigators

  • Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China

  • Groupe Hospitalier de la Region de Mulhouse et Sud Alsace

Related Conditions

  • Myopia Degenerative1

Activity Timeline